Checkpoint Immunotherapy in Pediatric Oncology: Will We Say Checkmate Soon?
Immune checkpoint inhibitors (ICIs) are a relatively new class of immunotherapy which bolsters the host immune system by “turning off the brakes” of effector cells (e.g., CTLA-4, PD-1, PD-L1). Although their success in treating adult malignancy is well documented, their utility in pediatric cancer h...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI AG
2023-12-01
|
| Sarja: | Vaccines |
| Aiheet: | |
| Linkit: | https://www.mdpi.com/2076-393X/11/12/1843 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|